Carthamus tinctorius

Carthamus tinctorius, commonly known as safflower, contains key bioactive flavonoids including hydroxysafflor yellow A (HSYA) and carthamin, which exert antioxidant and neuroprotective effects primarily by scavenging reactive oxygen species and inhibiting glutamate-induced excitotoxicity. It holds an EMA monograph status and has been studied in preliminary animal models for cerebral protection and osteoblast defense against oxidative damage.

Origin & History

Carthamus tinctorius L., commonly known as safflower, is an annual herbaceous plant in the Asteraceae family, native to the Middle East, India, and China, now cultivated worldwide. The dried flowers are the primary medicinal part, extracted using water or ethanol to yield bioactive compounds rich in chalcone glycosides and quinochalcone C-glycosides.

Historical & Cultural Context

Carthamus tinctorius flowers have been used for centuries in Traditional Persian (Kafesheh), Chinese (Honghua), and folk medicine for cardiovascular diseases, cerebrovascular issues, menstrual problems, and trauma-related pain. The Chinese Pharmacopoeia lists it for cerebral and cardiovascular conditions, with water extracts traditionally applied as anticoagulants and antihypertensives.

Health Benefits

• Neuroprotective effects: Water extracts inhibited glutamate-induced cell death in rat C6 glia cells and reduced oxidative markers in rat cerebrum (preliminary evidence from animal studies)
• Antioxidant protection: Demonstrated protection in osteoblasts by reducing malondialdehyde and other oxidative stress markers (in vitro evidence only)
• Bone health support: Hydroxysafflor yellow A inhibits bone resorption by reducing cyclooxygenase-2 and prostaglandin E2 (preliminary in vitro evidence)
• Cardiovascular support: Traditional use for cardiovascular conditions with anticoagulant and vasodilatory properties (traditional evidence only, no human clinical trials)
• Anti-inflammatory effects: Linked to water extracts through reduction of inflammatory markers (preliminary animal evidence)

How It Works

Hydroxysafflor yellow A (HSYA), the primary chalcone glycoside in Carthamus tinctorius, inhibits glutamate-induced excitotoxicity by reducing intracellular calcium overload and suppressing reactive oxygen species (ROS) accumulation in glial cells. Carthamin and HSYA also downregulate lipid peroxidation markers including malondialdehyde (MDA) by activating the Nrf2/HO-1 antioxidant pathway, increasing superoxide dismutase (SOD) activity. Additionally, HSYA modulates the NF-κB signaling cascade, dampening pro-inflammatory cytokine release in neuronal and bone cell models.

Scientific Research

The research dossier reveals no human clinical trials, RCTs, or meta-analyses for Carthamus tinctorius have been conducted. Available evidence consists entirely of preclinical studies including in vitro experiments and animal models, with no PubMed PMIDs for human trials provided.

Clinical Summary

Most available evidence for Carthamus tinctorius derives from in vitro and rodent studies rather than robust human clinical trials. Animal studies demonstrated that water extracts of safflower reduced glutamate-induced cell death in rat C6 glia cells and lowered oxidative markers such as MDA in rat cerebrum tissue, though sample sizes and standardization vary across studies. In osteoblast models, safflower extracts showed measurable reductions in oxidative stress biomarkers, but no large-scale randomized controlled trials in humans have yet confirmed these effects. The overall evidence base remains preliminary, and the EMA monograph reflects traditional use rather than established clinical efficacy at specific dosages.

Nutritional Profile

Carthamus tinctorius (safflower) contains the following nutritionally and biochemically relevant components: **Fatty acids (seed oil):** Linoleic acid (omega-6) dominates at 68–83% of total fatty acids in high-linoleic varieties; oleic acid (omega-9) ranges from 75–80% in high-oleic varieties; palmitic acid ~6–7%; stearic acid ~2–3%. **Protein (seeds/meal):** Crude protein content in defatted safflower meal ranges from 40–50% by dry weight, containing essential amino acids including lysine (~3.2 g/100g protein), methionine (~2.1 g/100g protein), and arginine (~8.5 g/100g protein). **Bioactive flavonoids and pigments:** Hydroxysafflor yellow A (HSYA) is the predominant water-soluble chalcone glycoside in florets, typically present at 1–3% of dried floret weight; safflower yellow A and B (carthamin precursors) also present; carthamin (red pigment) forms upon enzymatic oxidation. **Tocopherols (seed oil):** Alpha-tocopherol at approximately 34–39 mg/100g oil; gamma-tocopherol at ~1–2 mg/100g oil. **Phytosterols:** Beta-sitosterol (~150–200 mg/100g oil), campesterol (~30–50 mg/100g oil). **Minerals (seeds):** Potassium ~690 mg/100g, phosphorus ~644 mg/100g, magnesium ~130 mg/100g, calcium ~60 mg/100g, iron ~6.4 mg/100g. **Fiber:** Total dietary fiber in seed meal approximately 35–40% dry weight, predominantly insoluble. **Bioavailability notes:** HSYA has limited oral bioavailability due to poor intestinal absorption; fatty acid bioavailability from oil is high (>90%); tocopherol absorption is fat-dependent and estimated at 20–40% under normal dietary conditions.

Preparation & Dosage

No clinically studied human dosage ranges are established for Carthamus tinctorius extracts or standardized forms. Animal studies used 0.2-2 mg/kg/day but these cannot be translated to human recommendations. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Ginkgo biloba, Rhodiola rosea, Curcuma longa, Green tea extract, Resveratrol

Safety & Interactions

Carthamus tinctorius is generally considered well-tolerated at traditional doses, but high doses of safflower oil or extracts may exert anticoagulant effects by inhibiting platelet aggregation, raising concern for interactions with anticoagulant or antiplatelet drugs such as warfarin or aspirin. Individuals with known allergies to Asteraceae/Compositae family plants (including ragweed, chrysanthemums, and daisies) are at increased risk of hypersensitivity reactions. Use during pregnancy is contraindicated, as safflower has historically been associated with uterotonic activity and potential to stimulate uterine contractions. No well-documented herb-drug interaction studies exist in humans, so caution is advised when combining with blood pressure medications or hormonal therapies.